These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18347364)

  • 1. NSAIDs and cardiovascular disease.
    Patrignani P; Capone ML; Tacconelli S
    Heart; 2008 Apr; 94(4):395-7. PubMed ID: 18347364
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.
    ; Wilcox CM; Allison J; Benzuly K; Borum M; Cryer B; Grosser T; Hunt R; Ladabaum U; Lanas A; Paulus H; Regueiro C; Sandler RS; Simon L
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1082-9. PubMed ID: 16877048
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M; Ruschitzka F
    Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs].
    Lange H; Eberhart L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug safety of NSAIDs and COX-2 inhibitors].
    Herdegen T; Fauler J
    Med Monatsschr Pharm; 2006 Apr; 29(4):122-8. PubMed ID: 16628961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].
    Nurmohamed MT
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1313; author reply 1313-4. PubMed ID: 17624165
    [No Abstract]   [Full Text] [Related]  

  • 7. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
    Woodruff T
    Intern Med J; 2006 Dec; 36(12):797-8; author reply 798-9. PubMed ID: 17096747
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular adverse reactions from NSAIDs are more than COX-2 inhibition alone.
    Rainsford KD
    Rheumatology (Oxford); 2010 May; 49(5):834-6. PubMed ID: 20097907
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs.
    Patrono C
    Bull Mem Acad R Med Belg; 2010; 165(1-2):115-23; discussion 124. PubMed ID: 21162342
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
    Hinz B; Renner B; Brune K
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More evidence standard preventative measures can prevent COX-2 inhibitor-induced infarctions.
    Hellstrom HR
    Med Hypotheses; 2008 Nov; 71(5):819-20. PubMed ID: 18706771
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter by Cen regarding article, "Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas".
    Cen YY
    Circulation; 2007 Mar; 115(12):e348; author reply e349. PubMed ID: 17389275
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory drugs--changes in prescribing may be warranted.
    Madhok R; Wu O; McKellar G; Singh G
    Rheumatology (Oxford); 2006 Dec; 45(12):1458-60. PubMed ID: 17077156
    [No Abstract]   [Full Text] [Related]  

  • 14. What price pain relief?
    Hochman JS; Shah NR
    Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335
    [No Abstract]   [Full Text] [Related]  

  • 15. Mayo Clinic office visit. NSAIDs and cardiovascular risks. An interview with Sharon Mulvagh, M.D.
    Mulvagh S
    Mayo Clin Womens Healthsource; 2010 Nov; 14(11):6. PubMed ID: 20881928
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analgesics, NSAIDS, and coxibs in rheumatic pain].
    Di Matteo L
    Reumatismo; 2006; 58 Spec No.1():84-9. PubMed ID: 23631071
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dosage on coxib- or nonsteroidal antiinflammatory drug-associated cardiovascular risk? Comment on the article by Solomon et al.
    Boers M
    Arthritis Rheum; 2007 Jan; 56(1):384; author reply 384. PubMed ID: 17195242
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future.
    Fiorucci S
    Gastroenterol Clin North Am; 2009 Jun; 38(2):315-32. PubMed ID: 19446261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Farkouh ME; Greenberg BP
    Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.